B. Riley Wealth Advisors’s BioNTech BNTX Stock Holding History

B. Riley Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$19.7K	–	1039
2025 Q3	$19.7K	Buy	+20,000	New	+$2.14M	﹤0.01%	1041

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

B. Riley Wealth Advisors's BNTX Position: Q4 2025 in Review

B. Riley Wealth Advisors sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 703 shares — an estimated $69.3K sold.

B. Riley Wealth Advisors first reported a position in BNTX in Q3 2020 and held it in 10 quarters. The position peaked at $1.17M in Q2 2021. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

B. Riley Wealth Advisors reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
B. Riley Wealth Advisors sold 703 BioNTech shares in Q4 2025, an estimated $69.3K.
B. Riley Wealth Advisors first reported a position in BioNTech in Q3 2020 and held it in 10 quarters.
B. Riley Wealth Advisors's BioNTech position peaked at $1.17M in Q2 2021.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.